RecruitingNot ApplicableNCT05989061

PEEK Versus Titanium Customized Healing Abutments

PEEK Versus Titanium Customized Healing Abutments: Evaluation of Peri-implant Soft Tissues and Sulcus Fluid Bacterial Load


Sponsor

Ain Shams University

Enrollment

26 participants

Start Date

Sep 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The study suggests that if the investigators used customized healing abutments synthesized from PEEK may have a favorable effect on peri-implant soft tissues regarding decreased plaque accumulation and healing stimulation compared to the customized conventional titanium healing abutments.


Eligibility

Min Age: 20 YearsMax Age: 50 Years

Inclusion Criteria12

  • Patients should be systematically free from any disease as according to Cornell Medical Index-Health Questionnaire .
  • Both genders.
  • Age from 20-50 years.
  • Missing tooth in esthetic zone (Anterior/Premolar) to be restored with standard implant, with no need for additional bone and soft tissue augmentation procedures.
  • Implants primary stability ISQ ≥ 70 unites using the Osstell Mentor
  • BuccoLingual bone width ≥ 6 mm.
  • Mesio distal space ≥ 7 mm
  • Sound Mesial and distal neighboring teeth.
  • At least 6 natural teeth remaining in the same arch .
  • Mouth opening ≥ 30mm.
  • Enough keratinized mucosa.
  • Thick phenotype.

Exclusion Criteria3

  • Poor oral hygiene condition.
  • Pregnant and lactating females.
  • Smokers.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPEEK customized healing abutment

Guided delayed implant and a customized PEEK healing abutment placed simultaneously with implant surgery

DEVICETitanium customized healing abutment

Guided delayed implant and a customized Titanium healing abutment placed simultaneously with implant surgery


Locations(1)

Faculty of Dentistry Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05989061


Related Trials